Last updated on November 2019

A Study Investigating the Safety Tolerability and Efficacy of ASP7517 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML) and Relapsed/Refractory Higher Risk Myelodysplastic Syndrome (MDS)


Find a site near you

Start Over

Site JP81004

Maebashi, Japan
  Connect »